BetterLife comments on CEO's share position ownership
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 22 2025
0mins
BetterLife Pharma's Response: BetterLife Pharma issued a press release addressing the British Columbia Securities Commission's recent penalty, highlighting amendments made to past Management Information Circulars regarding CEO Ahmad Doroudian's ownership disclosures.
CEO's Ownership Increase: Dr. Doroudian has significantly increased his shareholding in BetterLife from approximately 5.8 million to 16 million shares through direct investment and salary settlements, expressing pride in his contributions and optimism about the company's future.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
